Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review)

In recent years, magnetic nanoparticles (MNPs) have demonstrated marked progress in the field of oncology. General nanoparticles are widely used in tumor targeting, and the intrinsic magnetic property of MNPs makes them the most promising nanomaterial to be used as contrast agents for magnetic reson...

Full description

Saved in:
Bibliographic Details
Published inMolecular and clinical oncology Vol. 7; no. 5; pp. 738 - 746
Main Authors Wu, Meijia, Huang, Shengwu
Format Journal Article
LanguageEnglish
Published England D.A. Spandidos 01.11.2017
Subjects
Review
treatment
cancer diagnosis
cancer
drug delivery
magnetic nanoparticles
Online AccessGet full text
ISSN2049-9450
2049-9469
DOI10.3892/mco.2017.1399

Cover

More Information
Summary:In recent years, magnetic nanoparticles (MNPs) have demonstrated marked progress in the field of oncology. General nanoparticles are widely used in tumor targeting, and the intrinsic magnetic property of MNPs makes them the most promising nanomaterial to be used as contrast agents for magnetic resonance imaging (MRI) and induced magnetic hyperthermia. The properties of MNPs are fully exploited when they are used as drug delivery agents, wherein drugs may be targeted to the desired specific location by application of an external magnetic field. Early diagnosis of cancer may be achieved by MRI, therefore, individualized treatment may be combined with MRI, so as to achieve the precise definition and appropriate treatment. In the present review, research on MNPs in cancer diagnosis, drug delivery and treatment has been summarized. Furthermore, the future perspectives and challenges of MNPs in the field of oncology are also discussed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2049-9450
2049-9469
DOI:10.3892/mco.2017.1399